Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Leukemia (2016) 30, 562–569. DOI: 10.1038/leu.2015.281
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2019
- Urheber
-
Gratwohl, A.
Pfirrmann, M.
Zander, A.
Kröger, N.
Beelen, D.
Novotny, J.
Nerl, C.
Scheid, C.
Spiekermann, K.
Mayer, J.
Sayer, HG
Falge, C.
Bunjes, D.
Döhner, H.
Ganser, A.
Schmidt-Wolf, I.
Schwerdtfeger, R.
Baurmann, H.
Kuse, R.
Schmitz, N.
Wehmeier, A.
Fischer, J. Th
Ho, AD
Wilhelm, M.
Goebeler, M-E
Lindemann, HW
Bormann, M.
Hertenstein, B.
Schlimok, G.
Baerlocher, GM
Aul, C.
Pfreundschuh, M.
Fabian, M.
Staib, P.
Edinger, M.
Schatz, M.
Fauser, A.
Arnold, R.
Kindler, T.
Wulf, G.
Rosselet, A.
Hellmann, A.
Schäfer, E.
Prümmer, O.
Schenk, M.
Hasford, J.
Heimpel, H.
Hossfeld, DK
Kolb, H-J
Büsche, G.
Haferlach, C.
Schnittger, S.
Müller, MC
Reiter, A.
Berger, U.
Saußele, S.
Hochhaus, A.
Hehlmann, R.
- URN
-
urn:nbn:de:bvb:20-opus-150368
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gratwohl, A.
- Pfirrmann, M.
- Zander, A.
- Kröger, N.
- Beelen, D.
- Novotny, J.
- Nerl, C.
- Scheid, C.
- Spiekermann, K.
- Mayer, J.
- Sayer, HG
- Falge, C.
- Bunjes, D.
- Döhner, H.
- Ganser, A.
- Schmidt-Wolf, I.
- Schwerdtfeger, R.
- Baurmann, H.
- Kuse, R.
- Schmitz, N.
- Wehmeier, A.
- Fischer, J. Th
- Ho, AD
- Wilhelm, M.
- Goebeler, M-E
- Lindemann, HW
- Bormann, M.
- Hertenstein, B.
- Schlimok, G.
- Baerlocher, GM
- Aul, C.
- Pfreundschuh, M.
- Fabian, M.
- Staib, P.
- Edinger, M.
- Schatz, M.
- Fauser, A.
- Arnold, R.
- Kindler, T.
- Wulf, G.
- Rosselet, A.
- Hellmann, A.
- Schäfer, E.
- Prümmer, O.
- Schenk, M.
- Hasford, J.
- Heimpel, H.
- Hossfeld, DK
- Kolb, H-J
- Büsche, G.
- Haferlach, C.
- Schnittger, S.
- Müller, MC
- Reiter, A.
- Berger, U.
- Saußele, S.
- Hochhaus, A.
- Hehlmann, R.
- Universität Würzburg
Entstanden
- 2019
Ähnliche Objekte (12)
Oral health status in adult patients with newly diagnosed acute leukemia
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
Intracranial hemorrhage in newly diagnosed non-promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
Sleep-disordered breathing in patients with newly diagnosed lung cancer
The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase
CXCR4-directed PET/CT in patients with newly diagnosed neuroendocrine carcinomas
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Oral health status in adult patients with newly diagnosed acute leukemia
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
Intracranial hemorrhage in newly diagnosed non-promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
Sleep-disordered breathing in patients with newly diagnosed lung cancer
The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase
CXCR4-directed PET/CT in patients with newly diagnosed neuroendocrine carcinomas
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Oral health status in adult patients with newly diagnosed acute leukemia
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
Intracranial hemorrhage in newly diagnosed non-promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
Sleep-disordered breathing in patients with newly diagnosed lung cancer
The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase
CXCR4-directed PET/CT in patients with newly diagnosed neuroendocrine carcinomas
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma